Lv2
140 积分 2023-11-22 加入
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
5天前
已完结
Do cancer survivors have an increased risk of developing subsequent cancer? A population-based study
9天前
已完结
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study
11天前
已完结
Colon, colorectal and all cancer incidence increase in the Young due to appendix reclassification
19天前
已完结
Latent class analysis-derived classification for cancer-specific death stratification of hepatocellular carcinoma
19天前
已完结
Osthole impairs mitochondrial metabolism and the autophagic flux in colorectal cancer
27天前
已完结
Qingyihuaji Formula promotes apoptosis and autophagy through inhibition of MAPK/ERK and PI3K/Akt/mTOR signaling pathway on pancreatic cancer in vivo and in vitro
28天前
已完结
Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression
28天前
已完结
Ganoderic acid D attenuates gemcitabine resistance of triple-negative breast cancer cells by inhibiting glycolysis via HIF-1α destabilization
28天前
已完结
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
30天前
已完结
皖公网安备34019202002308
